In a significant move for the burgeoning psychedelic industry, President Trump signed an executive order aimed at expediting the review of psychedelic therapies, as well as increasing federal research funding.
In a significant move for the burgeoning psychedelic industry, President Trump signed an executive order aimed at expediting the review of psychedelic therapies, as well as increasing federal research funding.






